Mei Gao | Pharmacology | Research Excellence Award

Published on by Global Scholar Awards

Prof. Mei Gao | Pharmacology | Research Excellence Award

Professor | Chongqing General Hospital, Chongqing University | China

Prof. Mei Gao is a researcher affiliated with Stony Brook University, specializing in pharmacology, neuroscience, cancer research, and stem cell biology. With an outstanding record of 2,501 citations, an h-index of 27, and an i10-index of 41, she has made significant contributions to neuroprotection, ischemia-reperfusion injury, and molecular mechanisms underlying neurological and oncological diseases. Her highly cited work on compounds such as pinocembrin and luteolin has advanced understanding of apoptosis, oxidative stress, and neurovascular protection. Collaborating extensively with international research teams, her studies bridge basic and translational science. Her research holds strong societal impact by supporting the development of innovative therapeutic strategies and improving outcomes in neurological and cancer-related conditions.

Citation Metrics (Google Scholar)

2501
1800
1200
600
0

Citations

2501

h-index

27

i10-index

41

Citations

h-index

i10-index

View Scopus Profile
 View ORCID Profile
 View Google Scholar Profile

Featured Publications

Patrick Blin | Pharmacology | Research Excellence Award

Published on by Global Scholar Awards

Dr. Patrick Blin | Pharmacology | Research Excellence Award

University of Bordeaux | France

Dr. Patrick Blin is a distinguished researcher at Université de Bordeaux, recognized for his significant contributions to pharmacoepidemiology, clinical research, and real-world evidence studies. With an impressive record of 133 publications, 3,897 citations, and an h-index of 29, his work demonstrates substantial scientific impact and global recognition. His research focuses on drug safety, cardiovascular diseases, diabetes, and healthcare outcomes, often utilizing large-scale national healthcare databases. He has collaborated extensively with a wide network of international researchers, enhancing the interdisciplinary scope of his work. His studies contribute to improving clinical decision-making, optimizing therapeutic strategies, and advancing public health policies, thereby delivering meaningful societal and healthcare impact.

Citation Metrics (Scopus)

3897
3000
2000
1000
0

Citations

3897

Documents

133

h-index

29

Citations

Documents

h-index

View Scopus Profile View ORCID Profile View ResearchGate Profile

Featured Publications

Lichun Zhao | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Lichun Zhao | Pharmacology | Best Researcher Award

Guizhou University of Traditional Chinese Medicine, China

Dr. Zhao Lichun is a highly accomplished researcher specializing in traditional Chinese medicine, trace elements, and health development. Currently serving as a postdoctoral fellow at Hong Kong Baptist University and doctoral supervisor at Guizhou University of Chinese Medicine, he has made significant contributions to advancing integrative medicine. He proposed the pioneering concept of “elemental traditional Chinese medicine” and identified rubidium as a key essential trace element for human health, shaping new perspectives in medical science. His career is distinguished by a strong record of innovation, leadership, and community engagement, reflected in more than 200 publications, numerous patents, and successful translation of research into certified medical products. Beyond his scientific work, Dr. Zhao plays an influential role in shaping academic development through editorial responsibilities, project evaluations, and leadership in professional organizations. With an outstanding academic profile and global collaborations, he continues to drive impactful research and nurture future scientific leaders.

Professional Profile 

Scopus Profile

Education

Dr. Zhao Lichun holds a Ph.D. in medical sciences with specialization in traditional Chinese medicine and trace element research. His doctoral training provided him with a solid foundation in advanced experimental methodologies, clinical translation, and interdisciplinary approaches that bridge medicine, chemistry, and biotechnology. Building on this expertise, he has pursued postdoctoral research at Hong Kong Baptist University, where he has expanded his international outlook and contributed to collaborative projects in health sciences. His academic journey reflects both depth and versatility, combining rigorous scientific inquiry with practical applications in drug discovery and product development. In addition to formal degrees, Dr. Zhao has continuously engaged in professional development through participation in academic training programs, international collaborations, and industry-focused initiatives. This blend of education and research experience has positioned him as a leading scholar capable of integrating traditional knowledge with modern scientific methods, thereby advancing the field of Chinese medicine and global healthcare.

Experience

Dr. Zhao Lichun’s professional experience spans academia, research leadership, and innovation-driven healthcare projects. At Guizhou University of Chinese Medicine, he serves as the Director of the Research Department and the Center for Trace Elements and Health Development, where he oversees scientific programs and mentors doctoral students. He also holds directorships at key laboratories in Guizhou and Guangxi, focusing on endangered medicinal material resources. His extensive project portfolio includes more than 30 national and international collaborations supported by the Ministry of Science and Technology of China and the National Natural Science Foundation of China. He has translated research into practice through the development of certified health products and clinical approval of innovative Chinese medicines, highlighting his capacity to merge academic excellence with real-world impact. In addition, his editorial leadership, project evaluation roles, and service in professional associations underscore his expertise in guiding research agendas, policy directions, and academic community building.

Research Interest

Dr. Zhao Lichun’s research interests lie at the intersection of traditional Chinese medicine, trace elements, and modern health sciences. He is especially recognized for introducing the concept of “elemental traditional Chinese medicine,” which explores the role of essential trace elements in human health and disease prevention. His pioneering work on rubidium as a critical trace element has opened new pathways for medical research and therapeutic development. Beyond elemental medicine, his interests encompass drug discovery, product development, and the integration of traditional knowledge with biotechnology and artificial intelligence for precision healthcare. He is also engaged in projects related to the conservation and utilization of endangered medicinal resources, bridging environmental sustainability with human health. By combining laboratory-based experimentation, clinical translation, and big data-driven approaches, Dr. Zhao aims to expand the scientific foundation of traditional Chinese medicine while contributing to global health innovation and interdisciplinary knowledge exchange.

Awards and Honors

Dr. Zhao Lichun has earned wide recognition for his scientific excellence and leadership, reflected in numerous prestigious awards and honors. He is the recipient of the National Youth Qihuang Scholar distinction, the Guangxi Youth Science and Technology Award, and has been recognized as an Outstanding Scholar in Guangxi. His leadership capabilities are further acknowledged through appointments such as Leader of High-Level Innovation Teams in Guangxi Higher Education Institutions and Academic and Technological Leader of Guangxi’s New Century talent programs. Additionally, he has received the Guangxi Science and Technology Progress Award, the Jilin Province Natural Science Award, and the China Industry-University-Research Cooperation Innovation Award, among others. Beyond individual achievements, he has been selected for Hong Kong’s “Excellent Talent Plan” and has contributed as an evaluation expert for major national projects and awards. These honors demonstrate his impactful contributions, sustained excellence, and influential role in advancing science and healthcare at both national and international levels.

Research Skills

Dr. Zhao Lichun possesses a diverse and advanced set of research skills spanning experimental science, translational medicine, and interdisciplinary collaboration. His expertise includes trace element analysis, molecular pharmacology, clinical research, and innovative drug development within the field of traditional Chinese medicine. He has strong capabilities in designing and managing large-scale research projects, demonstrated by his leadership of over 30 funded initiatives. His skills extend to scientific writing and dissemination, with more than 200 published papers and multiple edited monographs. He is adept at intellectual property management, evidenced by his extensive portfolio of patents and software copyrights, which translate laboratory findings into real-world applications. In addition, Dr. Zhao excels in academic leadership, editorial management, and evaluation of high-level research proposals. His ability to integrate advanced experimental methods with cross-disciplinary tools such as big data and artificial intelligence makes him a versatile researcher with both technical depth and strategic vision.

Publications Top Notes

Title: Bacteriostatic activity and mechanism of minerals containing rubidium
Journal: Science of Traditional Chinese Medicine
Year: 2025

Title: Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
Journal: Phytomedicine
Year: 2025
Citations: 3

Title: Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
Year: 2025
Citations: 13

Title: Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
Journal: ACS Applied Materials & Interfaces
Year: 2025

Title: Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
Journal: Biomedicine & Pharmacotherapy
Year: 2024
Citations: 22

Title: The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights
Year: 2025

Conclusion

Dr. Zhao Lichun’s outstanding record of scientific innovation, leadership in research, and service to the academic community makes him an exceptional candidate for the Best Researcher Award. His pioneering concepts in elemental traditional Chinese medicine, prolific publication and patent portfolio, leadership in multiple research organizations, and role in advancing international collaborations all underscore his suitability for this recognition. With his proven track record and strong potential for future breakthroughs, Dr. Zhao not only represents excellence in research but also embodies the qualities of a leader shaping the future of global science and healthcare.

Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Published on by Global Scholar Awards

Prof. Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Professor and Deputy Registrar at Anurag University, India

Dr. Padmanabha Rao Amarachinta, Professor and Deputy Registrar at Anurag University, Hyderabad, is a distinguished scholar in pharmaceutical sciences with over 23 years of experience in teaching, research, and industry. He holds a Ph.D. in Toxicology and has conducted advanced research at premier Indian institutions like IICT, CCMB, and NIN. Dr. Rao has published over 35 high-impact papers and authored several book chapters, notably in the area of nanomedicine. His innovations in drug delivery systems, particularly intranasal delivery of Rizatriptan, have earned him both Indian and German patents. He is a recipient of numerous awards including the “Distinguished Scientist Award” and “Leading Educationist of India.” His research interests include nanotechnology, drug discovery, and clinical research, and he is actively involved in mentoring Ph.D. scholars. Dr. Rao’s impactful contributions and leadership in pharmaceutical research make him a strong candidate for the Leading Innovations in Science Award.

Professional Profile 

Education🎓

Dr. Padmanabha Rao Amarachinta possesses a strong academic background in pharmaceutical sciences, culminating in a Ph.D. in Toxicology. His educational journey laid a solid foundation for his research and teaching career, with a focus on drug delivery systems and nanomedicine. Throughout his academic training, Dr. Rao demonstrated a keen interest in toxicology and pharmacology, which guided his doctoral research and subsequent scientific contributions. His advanced studies were complemented by research collaborations with prestigious Indian institutes such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and the National Institute of Nutrition (NIN), where he further deepened his expertise in biomedical sciences. His academic achievements reflect a rigorous and interdisciplinary approach to science, combining theoretical knowledge with practical research applications. Dr. Rao’s educational foundation continues to influence his innovative work in pharmaceutical technology, toxicology, and clinical research, enabling him to mentor scholars and contribute to cutting-edge scientific advancements.

Professional Experience📝

Dr. Padmanabha Rao Amarachinta brings over 17 years of diverse professional experience in academia and research, specializing in pharmaceutical sciences and toxicology. He has held significant academic positions, notably serving as an Associate Professor in the Department of Pharmacy at GITAM Deemed to be University. Dr. Rao has been instrumental in designing and delivering advanced curricula in pharmacology and toxicology, mentoring postgraduate and Ph.D. scholars, and fostering a research-driven academic environment. His professional journey includes collaborative research projects with prestigious institutions such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and National Institute of Nutrition (NIN). He has contributed to numerous national and international journals, reflecting his strong research acumen. Dr. Rao’s career highlights his commitment to academic excellence, interdisciplinary research, and innovation in drug delivery systems, making him a respected figure in both academic and scientific communities.

Research Interest🔎

Dr. Padmanabha Rao Amarachinta’s research interests lie primarily in the fields of pharmacology, toxicology, and drug delivery systems, with a special focus on the evaluation of herbal and synthetic drugs for their therapeutic efficacy and safety. He is particularly interested in the pharmacodynamic and pharmacokinetic profiling of novel drug candidates, including natural products with potential pharmacological activity. Dr. Rao explores innovative drug delivery mechanisms to enhance the bioavailability and targeted action of therapeutic agents, aiming to reduce side effects and improve patient outcomes. His research also delves into preclinical toxicological evaluations and the mechanisms of drug-induced organ toxicity. He is passionate about bridging traditional medicinal knowledge with modern pharmacological approaches through scientific validation of herbal formulations. With collaborations across premier research institutions, his work contributes significantly to advancements in evidence-based medicine and the development of safer, more effective treatment options for chronic and acute conditions.

Award and Honor🏆

Dr. Padmanabha Rao Amarachinta has received numerous awards and honors in recognition of his outstanding contributions to pharmaceutical sciences and academic excellence. He has been honored with prestigious fellowships and accolades from reputed institutions, highlighting his dedication to research and innovation in pharmacology and toxicology. Among his notable recognitions are awards for best research paper presentations at national and international conferences, acknowledging the scientific impact and quality of his work. He has also received institutional awards for his commitment to teaching and mentoring students, fostering a collaborative and intellectually stimulating academic environment. His contributions to the field have earned him invitations to serve as a keynote speaker and session chair at several scientific events. These honors reflect not only his professional achievements but also his influence in shaping the next generation of researchers and healthcare professionals, reinforcing his status as a respected figure in the pharmaceutical and biomedical research community.

Research Skill🔬

Dr. Padmanabha Rao Amarachinta possesses a comprehensive set of research skills that span across pharmaceutical sciences, pharmacology, and toxicology. His expertise lies in experimental design, data analysis, and interpretation, particularly in preclinical and in vitro models used for drug evaluation and safety profiling. He is highly skilled in molecular biology techniques, including PCR, ELISA, and Western blotting, which he employs in elucidating mechanisms of drug action and toxicity. Dr. Amarachinta is adept at handling laboratory instruments and software for statistical and bioinformatics analysis, facilitating accurate and reproducible research outcomes. His ability to draft scientific manuscripts, research proposals, and grant applications showcases his proficiency in academic writing and communication. Additionally, he has guided numerous postgraduate students, demonstrating his capability in mentoring and collaborative research. His methodical approach, critical thinking, and problem-solving abilities significantly contribute to his success in advancing pharmaceutical research and generating impactful scientific knowledge.

Conclusion💡

Dr. Padmanabha Rao Amarachinta exhibits strong qualifications for the Leading Innovations in Science Award. His deep-rooted contributions in nanomedicine, high-impact publications, international patents, and academic leadership make him a compelling nominee. He is a proven innovator in pharmaceutical sciences with an impressive blend of academic, research, and administrative excellence.

With minor emphasis on commercialization, global project leadership, and science communication, his already remarkable portfolio could be elevated to even greater heights.

Publications Top Noted✍️

  • Title: Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect
    Authors: PR Amarachinta, G Sharma, N Samed, AK Chettupalli, M Alle, JC Kim
    Year: 2021
    Citations: 77

  • Title: Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel
    Authors: AK Chettupalli, M Ananthula, PR Amarachinta, V Bakshi, VK Yata
    Year: 2021
    Citations: 51

  • Title: Pharmacological evaluation of herbal extracts for their in-vitro hypoglycemic activity
    Authors: AP Rao, KJ Kaiser Jamil
    Year: 2011
    Citations: 32

  • Title: Comparative toxicity of tetra ethyl lead and lead oxide to earthworms, Eisenia fetida (Savigny)
    Authors: JV Rao, P Kavitha, AP Rao
    Year: 2003
    Citations: 24

  • Title: Design, development and optimization of solid lipid nanoparticles of rizatriptan for intranasal delivery: in-vitro & in-vivo assessment
    Authors: V Bakshi, PR Amarachinta, AK Chettupalli
    Year: 2022
    Citations: 23

  • Title: Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: Statistical optimization and pharmacological evaluations
    Authors: A Unnisa, AK Chettupalli, RS Alazragi, W Alelwani, AM Bannunah, …
    Year: 2023
    Citations: 17

  • Title: Development and validation of glibenclamide in nanoemulsion formulation by using RP-HPLC
    Authors: AB Mohd, P Swathimutyam, AP Rao, N Shastri, PV Diwan
    Year: 2011
    Citations: 15

  • Title: Method development and validation for estimation of risperidone in novel liquisolid formulation by RP-HPLC
    Authors: K Sanka, S Bairi, R Gullapelli, S Bandi, AM Babu, AP Rao, PV Divana
    Year: 2014
    Citations: 9

  • Title: Formulation and evaluation of poly herbal liqui-solid compact for its anti-inflammatory effect
    Authors: AK Chettupalli, RR Amara, PR Amarachinta, RM Manda, BSR Garige, …
    Year: 2021
    Citations: 8

  • Title: Development and validation of simvastatin in microemulsion formulation using RP-HPLC
    Authors: C Srinivas, AB Mohd, S Huidrom, A Rao, PV Diwan
    Year: 2012
    Citations: 8

  • Title: Quality by Design approach for preparation, characterization, and statistical optimization of naproxen sodium-loaded ethosomes via transdermal route
    Authors: AK Chettupalli, S Ajmera, PR Amarachinta, RM Manda, RK Jadi
    Year: 2023
    Citations: 6

  • Title: Preclinical evaluation of polyherbal formulations: hypoglycemic activity in rats
    Authors: PR Amarachinta, KJ Kaiser Jamil
    Year: 2012
    Citations: 6

  • Title: Letter to Editor: Recent Advancement in Blood Cancer Research and Management
    Authors: MA Jahangir, AP Rao
    Year: 2019
    Citations: 4

Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Published on by Global Scholar Awards

Assist. Prof. Dr.Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, Iran

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, with a Ph.D. in Medical Nanotechnology from Tehran University of Medical Sciences. His research focuses on drug and vaccine delivery systems, nanoparticles for wound healing, and nanofiber-based wound dressings. He has published extensively in high-impact journals, contributing significantly to biomedical advancements, particularly in chitosan-based vaccine delivery, essential oil nanoemulsions, and cancer therapies. With expertise in polymeric nanoparticles, niosomes, and phytosomes, his work bridges fundamental research and practical medical applications. Additionally, he holds an MBA in Strategic Management, enhancing his ability to lead interdisciplinary projects. Despite his strong academic record, increased international collaborations, patents, and industry partnerships could further amplify his impact. Dr. Mehrabi’s dedication to innovation in nanomedicine and consistent research output make him a strong candidate for the Best Researcher Award, recognizing his contributions to advancing medical sciences

Professional Profile 

Education

Dr. Mohsen Mehrabi has a diverse and multidisciplinary educational background in medical sciences and nanotechnology. He earned his Ph.D. in Medical Nanotechnology from the School of Advanced Medical Technology at Tehran University of Medical Sciences (2012-2018), where he specialized in nanoparticle-based vaccine delivery systems. Prior to that, he completed his M.Sc. in Medical Nanotechnology at the same institution (2008-2011), focusing on chitosan nanoparticles for drug delivery. He also pursued an MBA in Strategic Management at Tehran University (2021-2022), enhancing his expertise in research leadership and project management. His undergraduate education includes a B.Sc. in Medical Laboratory Sciences from Jondi Shapour Medical University of Ahvaz (2005-2007) and an Associate Degree in Medical Laboratory Sciences from Shiraz University of Medical Sciences (2001-2003). His strong academic foundation in nanomedicine, biotechnology, and medical sciences has significantly contributed to his research in drug delivery, vaccine development, and biomedical applications.

Professional Experience

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at the School of Medicine, Shahroud University of Medical Sciences (2018–present). With expertise in nanomedicine, drug delivery systems, and biomedical applications, he has played a key role in advancing research on nanoparticle-based drug and vaccine delivery, wound healing, and cancer therapies. His professional journey includes extensive academic research, supervision of scientific projects, and collaboration with international experts in the field of nanotechnology. His work on polymeric nanoparticles, niosomes, phytosomes, and hydrogel-based wound dressings has led to multiple high-impact publications. Additionally, his MBA in Strategic Management has equipped him with leadership and project management skills, allowing him to contribute to research strategy and innovation. Dr. Mehrabi’s dedication to interdisciplinary research and translational science has positioned him as a leading figure in medical nanotechnology, making significant contributions to both academic and applied biomedical research.

Research Interest

Dr. Mohsen Mehrabi’s research interests focus on nanotechnology-driven solutions for drug and vaccine delivery, wound healing, and biomedical applications. His work primarily explores polymeric nanoparticles (chitosan and alginate), niosomes, and phytosomes for targeted drug and vaccine delivery systems, aiming to enhance therapeutic efficacy and immunogenicity. He is particularly interested in the development of nanoparticle-based vaccine carriers, including chitosan-loaded recombinant hepatitis B antigen, to improve immune response. His research extends to essential oil nanoemulsions for antimicrobial and therapeutic applications in both human and veterinary medicine. Additionally, he investigates hydrogel-based nanoparticles for wound healing and nanofiber mesh as advanced wound dressings. His interdisciplinary approach integrates nanomedicine, biotechnology, and pharmaceutical sciences to develop innovative and efficient drug delivery systems. Through his work, Dr. Mehrabi aims to bridge the gap between fundamental nanoscience and clinical applications, contributing to advancements in precision medicine and targeted therapies.

Award and Honor

There is no specific information provided about awards and honors received by Dr. Mohsen Mehrabi. However, given his significant contributions to the field of medical nanotechnology, his extensive research on drug and vaccine delivery systems, and his numerous high-impact publications, he is a strong candidate for academic recognition and prestigious research awards. His work on chitosan-based nanoparticles, essential oil nanoemulsions, and hydrogel-based wound dressings has advanced biomedical applications, making a notable impact in nanomedicine and biotechnology. Additionally, his leadership in interdisciplinary research and his role as an Assistant Professor at Shahroud University of Medical Sciences further highlight his academic excellence. While specific accolades are not listed, his dedication, innovation, and contributions to medical sciences make him a potential recipient of awards recognizing excellence in nanotechnology, drug delivery, and vaccine research. Further details on awards and honors could strengthen his professional profile.

Research Skill

Dr. Mohsen Mehrabi possesses advanced research skills in medical nanotechnology, drug delivery systems, and biomedical applications. His expertise includes the design, synthesis, and characterization of polymeric nanoparticles such as chitosan, alginate, niosomes, and phytosomes for targeted drug and vaccine delivery. He has extensive experience in nanoparticle formulation, stability assessment, and in vitro/in vivo evaluation of drug-loaded systems. His skills extend to hydrogel-based wound dressings, nanofiber mesh fabrication, and essential oil nanoemulsions for therapeutic applications. He is proficient in physicochemical characterization techniques, including spectroscopy, electron microscopy, and chromatographic methods, to analyze nanoparticle properties and drug release profiles. His ability to integrate nanotechnology, immunology, and pharmaceutical sciences enables him to develop novel therapeutic strategies. Additionally, his strategic research planning and project management skills, supported by his MBA in Strategic Management, enhance his ability to lead interdisciplinary studies and contribute to cutting-edge innovations in nanomedicine.

Conclusion

Dr. Mohsen Mehrabi has a remarkable research record in nanomedicine and drug delivery, making him a strong contender for the Best Researcher Award. His work has significant scientific merit, real-world medical applications, and global relevance. Strengthening industry collaborations, patenting innovations, and increasing international leadership roles could further solidify his candidacy.

Publications Top Noted

  1. Title: Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat

    • Authors: Mahboubi Kancha M., Alizadeh M., Mehrabi M.
    • Year: 2024
    • Citation: 2

  2. Title: Isolation and Characterization of Extracellular Vesicles of Chick Embryo Blood

    • Authors: Rezakhania L., Gharibshahian M., Zamani S., Mehrabi M., Alizadeh M.
    • Year: 2024
    • Citation: 1

 

 

You said:
Craft compelling and forward-looking web content for the ‘Pharmacology’ Begin with a very short introduction and very short

Rushit Lodaya | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Dr. Rushit Lodaya | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Director at GSK, United States

Rushit N. Lodaya is an accomplished leader in vaccine formulation and drug product R&D, with over a decade of expertise in developing innovative delivery platforms for nucleic acids, adjuvants, and protein antigens. He specializes in lipid nanoparticle (LNP) formulations for RNA delivery, optimizing thermostable formulations, and advancing alternative drying technologies. His contributions include multiple patents, impactful publications, and leadership roles in cross-functional collaborations, including partnerships with organizations like the NIH. A strong advocate for innovation, Rushit has significantly influenced the fields of mRNA vaccines and adjuvant development through his research and mentorship. He emphasizes a “patent-first” strategy while promoting knowledge sharing through guest editing and academic collaborations. Dedicated to sustainability and translational research, he integrates cutting-edge science with practical applications. Rushit’s leadership, scientific contributions, and commitment to fostering talent make him a standout researcher advancing the frontiers of biopharmaceuticals and vaccine technology.

Professional Profile

Education

Rushit N. Lodaya has a strong academic foundation that underpins his expertise in pharmaceutical and vaccine research. He earned his Ph.D. from Northeastern University, Boston, as a GSK Fellow, where his research focused on developing and characterizing novel self-emulsifying adjuvant systems containing α-tocopherol. Under the guidance of Dr. Mansoor M. Amiji and Dr. Derek T. O’Hagan, he conducted innovative studies to enhance immune responses in vaccine formulations, including in vivo evaluations of adjuvants and lyophilization processes for single-vial vaccines. Prior to this, he pursued undergraduate research at Mumbai University, where he formulated and evaluated sustained-release drug delivery systems. His educational journey is marked by a blend of rigorous academic research and practical applications, equipping him with a robust skill set in formulation sciences, drug delivery, and vaccine development. This educational background laid the groundwork for his impactful career in advancing cutting-edge pharmaceutical and biopharmaceutical technologies.

Professional Experience

Rushit N. Lodaya has over a decade of professional experience in pharmaceutical and biopharmaceutical research, specializing in vaccine formulation, drug delivery systems, and lipid nanoparticle (LNP) technologies. Currently serving as Associate Director of RNA Delivery Sciences at GSK Vaccines, he leads strategies to advance mRNA delivery platforms and novel characterization tools. Previously, as an Expert Scientist at GSK, he spearheaded initiatives to optimize mRNA-LNP formulations, improve vaccine adjuvant processes, and establish external collaborations for drug product innovation. His earlier roles include significant contributions to Phase III clinical development, process transfer for GMP manufacturing, and formulation of protein antigens. At Cubist Pharmaceuticals, he worked on early-stage formulations for novel antibiotics and post-operative pain management. Rushit’s experience also encompasses academic roles, supervising Ph.D. students and guest editing for journals. His dynamic career blends technical expertise, innovative research, and leadership, driving advancements in vaccine and therapeutic development to address critical global health needs.

Research Interests

Rushit N. Lodaya’s research interests lie at the intersection of vaccine formulation science, advanced drug delivery systems, and pharmaceutical innovation. He is particularly focused on developing lipid nanoparticle (LNP) platforms for RNA delivery, optimizing their composition, stability, and scalability for clinical applications. His work extends to creating novel adjuvants and understanding their mechanisms to enhance immune responses. Rushit is also deeply invested in exploring alternative drying technologies, such as lyophilization, to achieve thermostable formulations, crucial for vaccines’ global accessibility and distribution. He is enthusiastic about tackling challenges in intracellular delivery, improving endosomal escape, and enabling co-delivery systems for therapeutic and prophylactic applications. Committed to translational research, Rushit seeks to bridge the gap between preclinical discoveries and real-world implementation, addressing pressing public health needs. His passion for innovation and sustainability aligns with his goal of advancing next-generation biopharmaceuticals and vaccines that are efficient, stable, and globally impactful.

Awards and Honors

Rushit N. Lodaya has been recognized for his outstanding contributions to vaccine research and pharmaceutical sciences through various awards and honors. As a recipient of the prestigious GSK Fellowship during his Ph.D. at Northeastern University, he demonstrated exceptional research capabilities in adjuvant systems and vaccine delivery. His innovative work has earned him multiple patents, including breakthroughs in lipid nanoparticle formulations and freeze-dried RNA vaccines, highlighting his commitment to advancing cutting-edge technologies. Rushit has also been invited to serve as a guest editor for a special issue of MDPI Pharmaceutics, focusing on next-generation vaccine adjuvants, reflecting his thought leadership in the field. His role as a mentor and collaborator has further solidified his reputation, as he supervises Ph.D. students and contributes to the scientific community through impactful publications and book chapters. These accolades underscore his dedication to innovation, collaboration, and advancing pharmaceutical sciences to address global health challenges.

Conclusion

Rushit N. Lodaya is a highly suitable candidate for the Best Researcher Award. His exceptional contributions to vaccine formulation, particularly in mRNA and LNP technologies, and his leadership in advancing innovative drug product solutions make him a strong contender. While he can expand his translational and collaborative impact, his sustained excellence, significant patents, publications, and mentorship strongly align with the award’s goals. Recognizing his efforts would celebrate and encourage further advancements in the critical field of vaccine R&D.

Publications top noted

  • The continued advance of vaccine adjuvants–‘we can work it out’
    • Authors: DT O’Hagan, RN Lodaya, G Lofano
    • Year: 2020
    • Citations: 117
  • “World in motion”–emulsion adjuvants rising to meet the pandemic challenges
    • Authors: DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano
    • Year: 2021
    • Citations: 73
  • Formulation design, optimization and in vivo evaluations of an α-tocopherol-containing self-emulsified adjuvant system using inactivated influenza vaccine
    • Authors: RN Lodaya, AP Kanitkar, K Friedrich, D Henson, R Yamagata, S Nuti, …
    • Year: 2019
    • Citations: 26
  • Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant
    • Authors: Y Wen, HV Trinh, CE Linton, C Tani, N Norais, DA Martinez-Guzman, …
    • Year: 2018
    • Citations: 17
  • Stable nanoemulsions for the delivery of small molecule immune potentiators
    • Authors: RN Lodaya, LA Brito, TYH Wu, AT Miller, GR Otten, M Singh, DT O’Hagan
    • Year: 2018
    • Citations: 14
  • Overview of vaccine adjuvants
    • Authors: RN Lodaya, S Gregory, MM Amiji, DT O’Hagan
    • Year: 2022
    • Citations: 7
  • Practical aspects of vaccine development
    • Authors: P Kolhe, S Ohtake
    • Year: 2021
    • Citations: 5
  • A Self-Emulsified Adjuvant System Containing the Immune Potentiator Alpha Tocopherol Induces Higher Neutralizing Antibody Responses than a Squalene-Only Emulsion When Evaluated
    • Authors: RN Lodaya, AP Kanitkar, A Ashraf, D Bamba, MM Amiji, DT O’Hagan
    • Year: 2023
    • Citations: 3
  • Lyophilized vaccine development
    • Authors: NM Payton, RN Lodaya, AM Padilla
    • Year: 2022
    • Citations: 3
  • Nanoscale Vaccines for Influenza
    • Authors: S Bhangde, RN Lodaya, MM Amiji
    • Year: 2023
    • Citations: 1
  • Microfluidic-Chip-Based Formulation and In Vivo Evaluations of Squalene Oil Emulsion Adjuvants for Subunit Vaccines
    • Authors: S Bhangde, S Fresnay-Murray, T Garretson, A Ashraf, DT O’Hagan, …
    • Year: 2024
    • Citations: Not yet available
  • Freeze-drying of lipid nanoparticles (lnps) encapsulating rna and formulations thereof
    • Authors: R Lodaya, P Pohlhaus, E Zecca, J Zhang, A Padilla, E Bourlès, J Enert
    • Year: 2024
    • Citations: Not yet available
  • “World in motion”-emulsion adjuvants rising to meet the pandemic challenges (Vol 6, 158, 2021)
    • Authors: DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano
    • Year: 2023
    • Citations: Not yet available
  • Author Correction: “World in motion”–emulsion adjuvants rising to meet the pandemic challenges
    • Authors: DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano
    • Year: 2023
    • Citations: Not yet available
  • Review 2: “A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability”
    • Authors: HM Niknam, NS Savar
    • Year: 2022
    • Citations: Not yet available

Lakshmanan Govindan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Dr.  Lakshmanan Govindan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at Saveetha Medical College and Hospital, India

Dr. Sheryene Tejeda, PhD, is an accomplished medical scientist with over 15 years of experience in clinical and scientific environments. Based in Palm Beach Gardens, Florida, she has played key roles in advancing medical research and developing innovative therapeutic protocols. Her expertise spans diverse fields such as oncology, neurology, and behavioral health. Dr. Tejeda has been instrumental in her positions, including Lead Medical Scientist at Medicinal Technologies, Contract Co-occurring Consultant, and Clinical Research Associate, where she contributed to cutting-edge research and patient care strategies. Her career is marked by a deep commitment to integrating science and holistic health approaches.

Professional Profile

Education

Dr. Tejeda’s academic background is as impressive as her professional career. She earned her PhD in Biomedical Science from Einstein Medical School, laying a strong foundation for her research in complex medical conditions. Additionally, she holds two Master’s degrees—one in Forensic Science and another in Health Science. These advanced studies equipped her with a multidisciplinary approach to healthcare, combining rigorous scientific methodology with a focus on human health outcomes. Dr. Tejeda also earned a Bachelor’s degree in Communications and Psychology, highlighting her interest in understanding human behavior alongside her scientific expertise.

Professional Experience

Dr. Tejeda’s extensive professional experience includes leadership roles in both clinical research and therapeutic development. As Lead Medical Scientist at Medicinal Technologies, she spearheaded research initiatives aimed at improving patient care through innovative medicinal approaches. Her role as a Contract Co-occurring Consultant involved working with individuals facing both mental health and substance use challenges, underscoring her commitment to integrative healthcare. In addition to her clinical work, Dr. Tejeda served as a Clinical Research Associate, contributing to various oncology and neurology trials. Her work across these roles highlights her versatility and leadership in advancing medical science.

Research Interests

Dr. Tejeda’s research interests are diverse and deeply rooted in her passion for integrative therapies and patient-centered care. She is particularly focused on oncology, where she investigates novel therapeutic approaches to cancer treatment. Additionally, she has a keen interest in neurology, exploring the intersections of neuroscience, behavior, and mental health. Her research also extends into behavioral health, where she looks at co-occurring disorders and the development of more effective treatment protocols. Dr. Tejeda’s interdisciplinary approach allows her to contribute meaningful insights into complex health challenges, with a focus on improving both treatment outcomes and patient quality of life.

Awards and Honors

Throughout her career, Dr. Tejeda has received numerous awards and recognitions for her contributions to medical research and healthcare. Her innovative work in oncology and neurology has been particularly lauded, earning her accolades within the scientific community. Additionally, her efforts in integrative and patient-focused care have resulted in recognition for her commitment to improving therapeutic practices. While specific awards have marked her journey, it is her ongoing dedication to advancing medical science and holistic health that continues to distinguish her as a leader in her field. Her work remains an inspiration to her colleagues and the broader medical community.

Conclusion

Dr. Lakshmanan’s extensive experience in medicinal plant research, advanced laboratory techniques, and interdisciplinary publications make him a deserving candidate for the Best Researcher Award. His innovative work in cancer and diabetes treatments has potential for wide-reaching applications in healthcare. Strengthening his grant acquisition and international research collaborations would further solidify his standing as a leading researcher in his field.

Publication top noted

  • Kamakshi, S., Anantha Lakshmi, P., Shenbhagaraman, R., Lakshmanan, G., Selvakumari, J.
    Antibacterial and photo dye degradative ability of copper oxide nanoparticles from Pleurotus cystidiosus
    Nano Express, 2024, 5(2), 025029
    📝 0 Citations
  • Muthu, S., Gopal, V., AL-Younis, Z.K., Giuffrè, A.M., Govindan, L.
    Extraction, purification, and investigation of the antibacterial potential of lysozyme isolated from the latex of Calotropis procera
    European Food Research and Technology, 2024, 250(5), pp. 1401–1416
    📝 0 Citations
  • Lakshmanan, G., Altemimi, A.B., Sivaraj, C., Najm, M.A.A., Gamal Abedelmaksoud, T.
    Imperatorin from the aerial parts of Cleome viscosa L.: a characterization study and evaluation of the antibacterial activity
    Natural Product Research, 2024, 38(5), pp. 848–855
    📝 0 Citations
  • Maria Francis, Y., Karunakaran, B., Ashfaq, F., Govindan, L., Ponnusamy Kasirajan, S.
    Mercuric Chloride Induced Nephrotoxicity: Ameliorative Effect of Carica papaya Leaves Confirmed by Histopathology, Immunohistochemistry, and Gene Expression Studies
    ACS Omega, 2023, 8(24), pp. 21696–21708
    📝 3 Citations
  • Sivalingam, A.M., Altemimi, A.B., Abdul-Abbas, S.J., Cacciola, F., Devaraj, N.
    Anti-Hyperglycaemic properties of an ethanolic extract from Costus spicatus (jacq) on Streptozotocin-induced diabetic male albino Wistar rats
    Moroccan Journal of Chemistry, 2023, 11(4), pp. 917–931
    📝 0 Citations
  • Rengarajan, S., Thangavel, N., Sivalingam, A.M., Selvakumari, J., Pandian, A.
    Green synthesis and characterization of silver nanoparticles with different solvent extracts of Sesbania grandiflora (L.) Poiret and assessment of their antibacterial and antioxidant potentials
    Biomass Conversion and Biorefinery, 2023
    📝 5 Citations
  • Lakshmanan, G., Selvam, R., Altemimi, A.B., Jayalakshmi, G., Pratap-Singh, A.
    Phytochemical screening of ethanolic extracts of Cuminum cyminum L. seeds along with the evaluation of antidiabetic properties by molecular docking approach
    Natural Product Research, 2023, 37(4), pp. 681–686
    📝 3 Citations
  • Vijayaraj, R., Altaff, K., Lakshmanan, G., Palanisamy, M., Alothaim, A.S.
    Inhibitory Activity of Chitin, (2-Acetamido-2-Deoxy-Hexopyranose) against Penicillin-Binding Proteins of Staphylococcus aureus
    Coatings, 2022, 12(12), 1854
    📝 4 Citations
  • Radhakrishnan, M., Palayam, M., Altemimi, A.B., Cacciola, F., Govindan, L.
    Leucine-Rich, Potent Anti-Bacterial Protein against Vibrio cholerae, Staphylococcus aureus from Solanum trilobatum Leaves
    Molecules, 2022, 27(4), 1167
    📝 2 Citations
  • Rama, P., Baldelli, A., Vignesh, A., Murugesan, K., Pratap-Singh, A.
    Antimicrobial, antioxidant, and angiogenic bioactive silver nanoparticles produced using Murraya paniculata (L.) jack leaves
    Nanomaterials and Nanotechnology, 2022
    📝 14 Citations